|
All (n = 196)
|
Diarrhoea (n = 29)
|
No diarrhoea (n = 167)
|
---|
Age, mean (SD)
|
41 (7)
|
41 (7)
|
41 (7)
|
Male
|
93% (183)
|
97% (28)
|
93% (155)
|
Female
|
7% (13)
|
3% (1)
|
7% (12)
|
CD4 count, mean (IQR)
1
|
0.17 (0.04-0.29)
|
0.11 (0.01-0.20)
|
0.18 (0.04-0.29)
|
CDC stage
2
| | | |
1
|
22% (43)
|
9% (4)
|
91% (39)
|
2
|
29% (56)
|
13% (7)
|
88% (49)
|
3
|
49% (97)
|
19% (18)
|
81% (79)
|
Risk group
| | | |
Homosexual
|
85% (166)
|
17% (28)
|
83% (138)
|
Heterosexual
|
11% (21)
|
5% (1)
|
95% (20)
|
Haemophiliac
|
1% (2)
|
0% (0)
|
100% (2)
|
Intravenous drug use
|
4% (7)
|
0% (0)
|
100% (7)
|
Blood transfusion
|
1% (1)
|
0% (0)
|
100% (1)
|
HIV-1 SI phenotype
|
32% (62)
|
21% (13)
|
79% (49)
|
P24 antigen in serum
|
16% (32)
|
3% (1)
|
97% (31)
|
HIV-1 RNA load >4.9 × 10
4
copies/ml
|
51% (99)
|
19% (19)
|
81% (80)
|
-
1IQR = inter quartile range.
-
2Stage 1: symptom free, 2: AIDS related symptoms that were not AIDS defining, 3: AIDS defining illness according to the CDC classification [30].